Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01235390 · ClinicalTrials.gov registry record · Phase 1

Effects of the Consumption of California Walnuts on Cardiovascular Health

A Phase 1 study, sponsored by University of California, Davis.

Completed
Registry status
Phase 1
Development phase
36
Enrollment target

NCT01235390 is a Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 36 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01235390, a Phase 1 study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
Phase 1
Development phase
36 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effects of the 4-week consumption of California walnuts on vascular function and immune health in postmenopausal women of ages 50-70. Primary outcome measures: * vascular endothelial function * platelet reactivity * indoleamine 2, 3-deoxygenase (IDO) Secondary outcome measures: * relationship of walnut intake to lipoprotein, fatty acids and oxylipins

Interventions

  • DIETARY_SUPPLEMENT Walnuts

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2010-10
Est. Completion 2012-06
Phase Phase 1

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT01235390

The ClinicalTrials.gov registry entry for NCT01235390 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Walnuts is the first listed.

NCT01235390 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01235390 about?

NCT01235390 is a clinical study titled "Effects of the Consumption of California Walnuts on Cardiovascular Health". The purpose of this study is to determine the effects of the 4-week consumption of California walnuts on vascular function and immune health in postmenopausal women of ages 50-70. Primary outcome measures: * vascular endothelial function * platelet reactivity * indoleamine 2, 3-deoxygenase (IDO) ...

What is the current status of trial NCT01235390?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2010-10. Estimated completion is 2012-06.

What interventions are being tested in trial NCT01235390?

The interventions under investigation include: Walnuts (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01235390?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.